Company

One Biosciences SAS

One Biosciences develops AI-powered single-cell diagnostic platforms for cancer treatment and research.

About

One Biosciences uses AI-powered single-cell technologies to analyze tumors and support oncology treatment decisions. Its OneMap™ platform provides reports from tumor biopsies, while OneCure™ supports patient selection and biomarker identification for clinical trials. Founded in 2020 and based in Paris, France, it raised EUR 15.000 mn in Series A funding in July 2025, co-led by Redmile Group and Blast.Club, with Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures, and Kima Ventures participating.

2Funding rounds

9Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in